Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Hypoglycemic Agents and CSII in Newly-diagnosed Type 2 Diabetes
NCT01471808Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2011
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of metformin, pioglitazone, sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Sun Yat-sen University. Started Oct 2011; status: completed.
02
Drugs
metforminpioglitazonesitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01471808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471808.